Mioratrina en es it fr

Mioratrina Brand names, Mioratrina Analogs

Mioratrina Brand Names Mixture

  • No information avaliable

Mioratrina Chemical_Formula


Mioratrina RX_link


Mioratrina fda sheet

Mioratrina msds (material safety sheet)

Mioratrina Synthesis Reference

Berger, Ludwig, U.S. Pat. 2,937,119 (1960)

Mioratrina Molecular Weight

260.33 g/mol

Mioratrina Melting Point

92-93 oC

Mioratrina H2O Solubility

0.3 mg/ml

Mioratrina State


Mioratrina LogP


Mioratrina Dosage Forms


Mioratrina Indication

For the relief of discomfort associated with acute, painful, musculoskeletal conditions.

Mioratrina Pharmacology

Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.

Mioratrina Absorption

No information avaliable

Mioratrina side effects and Toxicity

Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives

Mioratrina Patient Information

Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose therapy.

Mioratrina Organisms Affected

Humans and other mammals